Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
Thumbnail

Most hospitals are not complying with price transparency laws

Hospitals have been required to post their prices of their 300 most common procedures since Jan. 1, 2021. However, a majority of providers are still not fully complying. 

Thumbnail

Breaking: Supreme Court overturns Roe v. Wade

The U.S. Supreme Court has decided to overturn Roe v. Wade, which guaranteed the Constitutional right to abortion access for nearly 50 years.

Thumbnail

FDA rules Juul vape products can’t be marketed, sold

The move means Juul Labs cannot sell and distribute its products. Plus, Juul must remove products that are currently on the U.S. market or risk enforcement action.

 

Arl Van Moore, MD, American College of Radiology (ACR) delegate to the American Medical Association (AMA) House of Delegates, former ACR president, chairman of the ACR Board and former CEO of Strategic Radiology, discusses two radiology related policy decisions at the AMA 2022 meeting. These included a AMA policy on the iodine contrast shortage and AUC CDS. #AMA #AMA22 #AMAmtg #AMA175 #ACR

VIDEO: Radiology takeaways from the 2022 AMA meeting

Arl Van Moore, MD, American College of Radiology (ACR) delegate to the American Medical Association House of Delegates, former ACR president, chairman of the ACR Board and former CEO of Strategic Radiology, discusses radiology-related policy decisions at the AMA 2022 meeting.

The ASNC is one of several medical imaging societies asking Congress to repeal the appropriate use criteria (AUC) criteria mandate. They say it poses issues for clinicians and is becoming outdated by changes in CMS payment systems. The AUC requirements call for documentation using CVMS authorized software in order to show advanced imaging such as nuclear and CT is justified, or else Medicare payments might be withheld.

VIDEO: AMA will ask Congress to revise clinical decision support mandate for cardiac imaging

American Society of Nuclear Cardiology (ASNC) delegates to the American Medical Association (AMA) House of Delegates 2022 meeting Stephen Bloom, MD, and Nishant Shah, MD, explain a new AMA policy asking Congress to revise its clinician decision support mandate. 

Thumbnail

The 10 healthiest communities in the US

The ranking, courtesy of U.S. News & World Report, was designed to educate and inform consumers and policymakers on what’s happening in their communities.

Alex Ding, MD, radiologist and incoming AMA Board trustee, explains the new AMA policy that calls on Ciongress to change the requirements of the CMS requirement for appropriate use criteria clinical decision support software for all advanced imaging exams, including CT and MRI. #AMA #AMAmtg #AMA175 #AUC

VIDEO: AMA will ask Congress to change mandate on appropriate use criteria clinical decision support

Alexander Ding, MD, a radiologist and incoming American Medical Association (AMA) Board of Trustees member, explains the new AMA policy calling on Congress to change the language and implementation of the current Medicare mandate that all advanced medical imaging needs certification.

The American Medical Association (AMA) has declared climate change as a major healthcare emergency. Sunrises and sunsets have become increasingly red in recent years with additional particulate matter in the atmosphere from larger, massive wild fires. Photo by Dave Fornell

VIDEO: AMA says climate change is a public health emergency

Alexander Ding, MD, chair of the AMA Council on Science and Public Health, discusses a new AMA policy calling climate change a healthcare crisis and outlines the need for action to mitigate its impact on public health.

Displaying 585 - 592 of 2773

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup